Lichenochemical Analysis and Cytotoxicity of Diploschistes ocellatus (Fr.) Norman

Document Type : Original paper


1 Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

2 Department of Pharmacognosy and Pharmaceutical Biotechnology, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.

3 Iranian Research Organization for Science and Technology (IROST) Tehran, Iran.

4 Department of Pharmacognosy, Faculty of Pharmacy, Islamic Azad University, Ayatollah Amoli Branch, Amol, Iran.

5 Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran.

6 Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.

7 Department of Pharmacology, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran.

8 Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

9 Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

10 Faculty of Land and Food Systems, University of British Columbia, Vancouver, BC, Canada.


Background and objectives: Diploschistes ocellatus (Fr.) Norman is a valuable lichen possessing various biological properties which has been traditionally used by indigenous people in southwest of Iran in the treatment of different disorders. The aim of the current study was to evaluate cytotoxicity of different fractions of D. ocellatus against breast cancer cell lines through MTT assay, as well as lichenochemical analysis of the most potent fraction. Also, ducking study was performed to investigate the isolated compounds-protein interactions. Methods: In this work, aqueous, acetone, chloroform, ethyl acetate, and methanol fractions of D. ocellatus were evaluated against three breast cancer cell lines (MCF-7, T-47D, and MDA-MB-231) via MTT assay. Furthermore, docking was performed using the routine method and default parameters of the AutoDock 4.2 software. Results:  The acetone fraction depicted the most potent cytotoxicity and was candidate for lichenochemical analysis, leading to the isolation and identification of stictic acid and 2-(7'-hydroxy-3,5,6,8-tetramethyl-9-oxooxonan-2-yl) propanoic acid. Docking study of isolated compounds based on the inhibition of survivin, revealed desired interactions with that of amino acid residues. Conclusion: Based on the obtained results, D. ocellatus can be considered as a natural source of biologically active compounds and complementary studies are in high demand.


Main Subjects

  • Tripathi M, Joshi Y. What are Lichenized Fungi? Endolichenic Fungi: Present and Future Trends. Uttarakhand: Springer, 2019.
  • Zambare VP, Christopher LP. Biopharmaceutical potential of lichens. Pharm Biol. 2012; 50(6): 778–798.
  • Gharshi A. Al-Shamel fi al-sinaat al-tibbiah. Tehran: Iran University of Medical Scienses,
  • Bhattacharyya S, Deep PR, Singh S, Nayak B. Lichen secondary metabolites and its biological activity. Am J Pharm Tech Res. 2016; 6(6): 1–17.
  • Luzina OA, Salakhutdinov NF. Usnic acid and its derivatives for pharmaceutical use: a patent review (2000–2017). Expert Opin Ther Pat. 2018; 28(6): 477–491.
  • Solárová Z, Liskova A, Samec M, Kubatka P, Büsselberg D, Solár P. Anticancer potential of lichens’ secondary metabolites. Biomolecules. 2020; 10(1): 87–117.
  • Mendili M, Essghaier B, Seaward M, Khadhri A. In vitro evaluation of lysozyme activity and antimicrobial effect of extracts from four Tunisian lichens: Diploschistes ocellatus, Flavoparmelia caperata, Squamarina cartilaginea and Xanthoria parietina. Arch Microbiol. 2021; 203(4): 1461–1469.
  • Mendili M, Bannour M, Araújo MEM, Aschi-Smiti S, Seaward MR, Khadhria A. Secondary metabolites and antioxidant capacity of the Tunisian lichen Diploschistes ocellatus (Ascomycota). Int J Med Mushrooms. 2019; 21(8): 817–
  • Neophytou CM, Trougakos IP, Erin N, Papageorgis P. Apoptosis deregulation and the development of cancer multi-drug resistance. Cancers. 2021; 13(17): 4363–4388.
  • Shiozaki A, Kataoka K, Fujimura M, Yuki H, Sakai M, Saito S. Survivin inhibits apoptosis in cytotrophoblasts. Placenta. 2003; 24(1): 65–76.
  • Lehner R, Bobak J, Kim NW, Shroyer AL, Shroyer KR. Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole. Obstet Gynecol.2001; 97(6): 965–970.
  • Albadari N, Deng S, Chen H, Zhao G, Yue J, Zhang S, Miller DD, Wu Z, Li W. Synthesis and biological evaluation of selective survivin inhibitors derived from the MX-106 hydroxyquinoline scaffold. Eur J Med Chem. 2021; 224: 113719–113781.
  • Jha BN, Shrestha M, Pandey DP, Bhattarai T, Bhattarai HD, Paudel B. Investigation of antioxidant, antimicrobial and toxicity activities of lichens from high altitude regions of Nepal. BMC Complement Altern Med. 2017; 17(1): 1–8.
  • Eftekhari M, Ardekani MRS, Amin M, Attar F, Akbarzadeh T, Safavi M, Karimpour-razkenari E, Amini M, Ismang M, Khanavi M. Oliveria decumbens, a bioactive essential oil: chemical composition and biological activities. Iran J Pharm Res. 2019; 18(1): 412-421.
  • Eftekhari M, Ardekani MRS, Amin M, Mansourian M, Saeedi M, Akbarzadeh T, Khanavi M. Anti-Helicobacter pylori compounds from Oliveria decumbens through urease inhibitory in-vitro and in-silico studies. Iran J Pharm Res. 2021; 20(3): 476-489.
  • Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson JA. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(16): 2785–2791.
  • Taheri S, Nazifi M, Mansourian M, Hosseinzadeh L, Shokoohinia Y. Ugi efficient synthesis, biological evaluation and molecular docking of coumarin-quinoline hybrids as apoptotic agents through mitochondria-related pathways. Bioorg Chem. 2019; 91: 103147–103163.
  • Fassihi A, Mahnam K, Moeinifard B, Bahmanziari M, Aliabadi HS, Zarghi A, Sabet R,  Salimi M, Mansourian Synthesis, calcium-channel blocking activity, and conformational analysis of some novel 1, 4-dihydropyridines: application of PM3 and DFT computational methods.  Med Chem Res. 2012; 21(10): 2749–2761.
  • Mahdavi M, Lavi MM, Yekta R, Moosavi MA, Nobarani M, Balalaei S. Evaluation of the cytotoxic, apoptosis inducing activity and molecular docking of spiroquinazolinone benzamide derivatives in MCF-7 breast cancer cells. Chem Biol Interact. 2016; 260: 232–242.
  • Chantalat L, Skoufias DA, Kleman JP, Jung B, Dideberg O, Margolis RL. Crystal structure of human survivin reveals a bow tie–shaped dimer with two unusual α-helical extensions. Mol Cell. 2000; 6(1): 183–189.
  • Javid A, Ahmadian S, Saboury A, Rezaei Zarchi S. Anticancer effect of doxorubicin loaded heparin based super-paramagnetic iron oxide nanoparticles against the human ovarian cancer cells. World Acad Sci Eng Technol. 2011; 50: 41–45.
  • Mishra S, Singh S. Identification of inhibitors against metastasis protein “Survivin:” in silico discovery using virtual screening and molecular docking studies. Pharmacogn Mag. 2017; 13(S4): 742–748.
  • Shakeel E, Akhtar S, Khan MKA, Lohani M, Arif JM, Siddiqui MH. Molecular docking analysis of aplysin analogs targeting survivin protein. Bioinformation. 2017; 13(9): 293–300.
  • Ismed F, Lohézic-Le Dévéhat F, Rouaud I, Ferron S, Bakhtiar A, Boustie J. NMR reassignment of stictic acid isolated from a Sumatran lichen Stereocaulon montagneanum (Stereocaulaceae) with superoxide anion scavenging activities. Z NaturforschC. 2017; 72(1-2): 55–62.
  • Fernández Brime S, Llimona X, Lutzoni F, Gaya E. Phylogenetic study of Diploschistes (lichen–forming Ascomycota: Ostropales: Graphidaceae), based on morphological, chemical, and molecular data. Taxon. 2013; 62(2): 267–280.
  • Lumbsch HT, Tehler A. A cladistic analysis of the genus Diploschistes (Ascomycotina, Thelotremataceae). Bryologist. 1998; 101(3): 398–403.
  • Tripathi AH, Negi N, Gahtori R, Kumari A, Joshi P, Tewari LM, Yogesh J , Rajesh B, Dalip KU. A review of anti-cancer and related properties of lichen-extracts and metabolites. Anti-Cancer Agents Med Chem. 2022; 22(1): 115–
  • Pejin B, Iodice C, Bogdanović G, Kojić V, Tešević V. Stictic acid inhibits cell growth of human colon adenocarcinoma HT-29 cells. Arab J Chem. 2017; 10(S1): 1240–1242.